(PDF) MA11.07 Expression of LAG-3 and NY-ESO-1 in Tumor

MA11.07 Expression of LAG-3 and NY-ESO-1 in Tumor Cells Is Promising Biomarker Predicting Durable Clinical Benefit of PD-1 Blockade in Advanced NSCLC

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.408

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

PD-1 Expression and Clinical PD-1 Blockade in B-Cell Lymphomas

English

Expression of LAG-3 and Efficacy of Combination Treatment With Anti-Lag-3 and Anti-Pd-1 Monoclonal Antibodies in Glioblastoma

International Journal of Cancer

Cancer Research

English

MA06.03 PD-1 and Id-1 Combined Blockade Impacts Tumor Growth and Survival Through PD-L1 Expression and Tumor Infiltration by Immune-Related Cells

Journal of Thoracic Oncology

Respiratory Medicine

English

LAG-3 and PD-1+LAG-3 Inhibition Promote Anti-Tumor Immune Responses in Human Autologous Melanoma/T Cell Co-Cultures

English

Deep Phenotypic Characterization of NY-ESO TCR Engineered T Cells and Tumor in Patients With Advanced Myeloma

Journal for ImmunoTherapy of Cancer

Molecular Medicine

Cancer Research

English

Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients With NY-ESO-1+ Cancers

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors

Journal of Immunology

English

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells

Infectious Diseases

English

PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?

Pancreas - Open Journal

English